| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Masja de Haas | Q47654799 |
| P2093 | author name string | C E Van der Schoot | |
| A Ait Soussan | |||
| G Bonsel | |||
| J Koelewijn | |||
| L G C Paget-Christiaens | |||
| P2860 | cites work | Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum | Q24567463 |
| Detection of tumor mutations in the presence of excess amounts of normal DNA. | Q30804424 | ||
| A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma | Q33361680 | ||
| Fetal cells in the maternal circulation: feasibility for prenatal diagnosis | Q33650187 | ||
| Detection of the placental epigenetic signature of the maspin gene in maternal plasma. | Q34078379 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Microsatellite alterations in plasma DNA of small cell lung cancer patients. | Q34394739 | ||
| Microsatellite alterations in serum DNA of head and neck cancer patients | Q34394745 | ||
| Prenatal sex determination by DNA amplification from maternal peripheral blood | Q34465871 | ||
| mRNA of placental origin is readily detectable in maternal plasma. | Q34960254 | ||
| PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies | Q35249607 | ||
| Maternal serum anti-D antibody concentration and assessment of rhesus isoimmunisation | Q35821725 | ||
| Recent advances in fetal nucleic acids in maternal plasma | Q36063025 | ||
| Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time | Q36274725 | ||
| Flow sorting of fetal erythroblasts using intracytoplasmic anti-fetal haemoglobin: preliminary observations on maternal samples | Q36793986 | ||
| MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. | Q36986986 | ||
| ABO and Rhesus phenotyping of fetal erythrocytes in the first trimester of pregnancy | Q43851655 | ||
| Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma | Q47391690 | ||
| Size distributions of maternal and fetal DNA in maternal plasma. | Q47432593 | ||
| Detection of fetal messenger ribonucleic acid in maternal blood to determine fetal RhD status as a strategy for noninvasive prenatal diagnosis | Q47685128 | ||
| Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. | Q50792929 | ||
| Fetal cell-free DNA circulates in the plasma of pregnant mice: relevance for animal models of fetomaternal trafficking. | Q50796210 | ||
| Enrichment of fetal trophoblast cells from the maternal peripheral blood followed by detection of fetal deoxyribonucleic acid with a nested X/Y polymerase chain reaction. | Q51032871 | ||
| Prenatal diagnosis of the fetal RhD blood type using a single fetal nucleated erythrocyte from maternal blood. | Q51036850 | ||
| Fetal RhD genotyping by maternal serum analysis: a two-year experience. | Q54677407 | ||
| Clinical applications of cell-free fetal DNA from maternal plasma. | Q54735498 | ||
| Earliest gestational age for fetal sexing in cell-free maternal plasma. | Q54736349 | ||
| Methods to Increase the Percentage of Free Fetal DNA Recovered From the Maternal Circulation | Q56001879 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Lack of Dramatic Enrichment of Fetal DNA in Maternal Plasma by Formaldehyde Treatment | Q58029623 | ||
| Fetal RhD genotyping in fetal cells flow sorted from maternal blood | Q71085865 | ||
| Maternal origin of nucleated erythrocytes in peripheral venous blood of pregnant women | Q71867152 | ||
| Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers | Q72217432 | ||
| Clinical experience: isolating trophoblasts from maternal blood | Q72764170 | ||
| Detection of fetal RhD sequence from peripheral blood of sensitized RhD-negative pregnant women | Q72891141 | ||
| Non-invasive RNA-based determination of fetal Rhesus D type: a prospective study based on 96 pregnancies | Q73078528 | ||
| Prenatal detection of rhesus D genotype | Q73107139 | ||
| Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization | Q73752750 | ||
| The effect of chorionic villus sampling on the number of fetal cells isolated from maternal blood and on maternal serum alpha-fetoprotein levels | Q73849638 | ||
| Cell-free fetal DNA is not present in plasma of nonpregnant mothers | Q76380362 | ||
| Detection of fetal RHD-specific sequences in maternal plasma | Q77429872 | ||
| Two-colour immunocytochemical staining of gamma (gamma) and epsilon (epsilon) type haemoglobin in fetal red cells | Q77687939 | ||
| Fetal RHD genotyping in maternal serum during the first trimester of pregnancy | Q78311739 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 53-57 | |
| P577 | publication date | 2006-03-29 | |
| P1433 | published in | Transfusion Clinique et Biologique | Q15758506 |
| P1476 | title | Non-invasive antenatal RHD typing | |
| P478 | volume | 13 |
| Q55266945 | A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women. |
| Q34556245 | A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales |
| Q51406742 | An international reference reagent for the detection of RHD and SRY DNA in plasma. |
| Q38239704 | Anti-D prophylaxis: past, present and future |
| Q56765605 | Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome |
| Q54342228 | Cell-free fetal DNA in specimen from pregnant women is stable up to 5 days. |
| Q38586467 | Considerations of red blood cell molecular testing in transfusion medicine |
| Q34132783 | Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study |
| Q36538133 | Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study |
| Q45984957 | Evaluation of single-nucleotide polymorphisms as internal controls in prenatal diagnosis of fetal blood groups. |
| Q36837125 | Fetal RHD Genotyping Using Real-Time Polymerase Chain Reaction Analysis of Cell-Free Fetal DNA in Pregnancy of RhD Negative Women in South of Iran. |
| Q33917070 | Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women |
| Q46444885 | Fetal RHD genotyping by PCR using plasma from D negative pregnant women |
| Q54393922 | Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation. |
| Q36861150 | Fetal blood group genotyping. |
| Q34472967 | Haemolytic disease of the fetus and newborn |
| Q43494882 | How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care |
| Q38178923 | Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care |
| Q50694346 | Large scale blood group genotyping. |
| Q22242632 | Large-scale blood group genotyping - clinical implications |
| Q35507579 | Non-Invasive Prenatal RHD Genotyping Using Cell-Free Fetal DNA from Maternal Plasma: An Italian Experience |
| Q56001887 | Non-invasive fetal RHD genotyping in the first trimester of pregnancy |
| Q47808590 | Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD. |
| Q87466211 | Noninvasive fetal RhD genotyping |
| Q54433693 | Noninvasive fetal RhD genotyping from maternal blood. |
| Q34192088 | Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience |
| Q47785370 | Noninvasive prenatal detection of chromosomal aneuploidies using different next generation sequencing strategies and algorithms |
| Q35034936 | Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD |
| Q34306068 | Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008 |
| Q54088983 | Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis. |
| Q37000825 | Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood. |
| Q22241774 | Red cell genotyping and the future of pretransfusion testing |
| Q36794228 | Reliable Determination of Fetal RhD Status by RHD Genotyping from Maternal Plasma |
| Q46172895 | Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis |
| Q27687533 | Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice |
| Q51899817 | Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium. |
| Q46227317 | Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark. |
| Q37397918 | Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands |
| Q34936608 | Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program |
| Q36861133 | The BloodGen project: toward mass-scale comprehensive genotyping of blood donors in the European Union and beyond |
| Q36423155 | The Glass Slide Extraction System Snap Card Improves Non-Invasive Prenatal Genotyping in Pregnancies with Antibodies |
| Q38584359 | The impact of digital DNA counting technologies on noninvasive prenatal testing |
| Q84511507 | The molecular genetics of blood group polymorphism |
Search more.